Kurome Therapeutics Closes $15 Million Series A
Financing Co-led by Medicxi and Affinity Asset Advisors Funding to Advance IRAK1/4 Inhibitor Platform Through IND-Enabling Studies Kurome Therapeutics, a preclinical stage company dedicated to...
Tag : human clinical trials
AI-Based Clinical Trial Matching Solution, Deep Lens’ Viper Expand
Deep Lens today announced a collaboration that will integrate Deep Lens’ artificial intelligence (AI)-based clinical trial screening and matching solution VIPER™ , into cancer research....
Hawthorne Effect Raises $20M A to Decentralize Clinical Trials
Northpond Ventures leads round alongside SignalFire and P5 Health Ventures Hawthorne Effect™, a solution for decentralizing clinical trials, today announced the successful closing of a $20...
ViAqua Therapeutics Announces $4.3 Million Investment
Financing will support the commercialization of the first product aimed at improving health in shrimp and support the development of additional products to improve aquatic...
entrinsic bioscience Secures $49 Million in Financing
– Groundbreaking Platform Poised to Disrupt Multiple Consumer Health and Therapeutic Markets – entrinsic bioscience, Working with Aon, Leverages its IP Portfolio to Secure Insurancebacked...
Stablix Therapeutics Launches with $63 Million Series A
Versant Ventures leads investment in first-in-category company with targeted protein stabilization platform Foundational know-how establishes leadership in the field Stablix Therapeutics, a biotechnology company pioneering...
Clinical AI Technology Leader Mendel Raises $18M in New Capital
Announces a first-of-its-kind Clinical Data Marketplace to source real world data with clinics and pharmaceutical companies Today, Mendel, the company behind the clinical AI platform...
Transine Therapeutics Closes Extended Seed Funding of £9.1 Million
New Company emerges from stealth with potential ground-breaking mRNA therapeutic platform to increase protein expression Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class...
Therapy based on Tech, Amyl Therapeutics Closes €18.3 Million
Funds will be used to advance amyloid fibrils specific ClariTY technology platform as a potential best-in-class therapy for patients with Amyloidosis Amyl Therapeutics (‘Amyl’), a...
Iksuda Therapeutics Closes $47 Million Financing Round
Funding to accelerate clinical progression of Iksuda’s pipeline of new generation of antibody drug conjugates, targeting tumours with high unmet need Investment round led by...